Crossmark

Quality improvement initiative to optimize use of rapid genomic sequencing in a level IV NICU

Crossref DOI link: https://doi.org/10.1038/s41372-025-02541-5

Published Online: 2026-01-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

D’Gama, Alissa M. https://orcid.org/0000-0002-2482-5328
Hu, Rachel S.

Del Rosario, Maya C.

Hills, Sonia

Park, Hannah J.

Mehra, Anna-Thérèse

Tannenbaum, Laura S.

Morton, Sarah U. https://orcid.org/0000-0002-7816-2646
Agrawal, Pankaj B.

Wojcik, Monica H. https://orcid.org/0000-0002-8162-5031
Funding

Funding for this research was provided by:

U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32 HD098061)

U.S. Department of Health & Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development (K23 HD102589)

U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (K23 NS140397)

U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (K08 HL157653)

U.S. Department of Health & Human Services | NIH | National Human Genome Research Institute (R01 HG011798)
License Information

Text and Data Mining valid from 2026-01-12

Version of Record valid from 2026-01-12
More Information

Article History

Received: 5 August 2025

Revised: 15 November 2025

Accepted: 5 December 2025

First Online: 12 January 2026

Competing interests

: MHW has consulted for Illumina and Sanofi and received speaking honoraria from Illumina and GeneDx. PBA has consulted for Illumina and GeneDx and received honoraria from each. The other authors declare no competing interests.

: The BCH Institutional Review Board approved this study with a waiver of informed consent. Data are reported per SQUIRE guidelines [ ].

Document is current

Any future updates will be listed below